The use of inhaled formoterol in the treatment of asthma
- 31 July 2006
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 97 (1) , 24-33
- https://doi.org/10.1016/s1081-1206(10)61365-8
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Formoterol provides long-lasting protection against exercise-induced bronchospasmAnnals of Allergy, Asthma & Immunology, 2002
- A Post-Marketing Surveillance Study of Formoterol (Foradil??)*Drug Safety, 2002
- Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trialJournal of Allergy and Clinical Immunology, 2001
- Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severityJournal of Allergy and Clinical Immunology, 1999
- A 3-Month Comparison of Formoterol with Terbutaline via Turbuhaler. A Placebo-Controlled StudyAnnals of Allergy, Asthma & Immunology, 1998
- Clinical Experience over Five Years of Daily Therapy with Formoterol in Patients with Bronchial AsthmaClinical Drug Investigation, 1997
- High affinity [3H]formoterol binding sites in lung: characterization and autoradiographic mappingEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Long- Versus Short-Acting ??2-AgonistsDrugs, 1994
- Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in childrenJournal of Allergy and Clinical Immunology, 1992
- Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.Thorax, 1992